Benzonatate is a non-narcotic cough
10 years or older:
Suppresses cough through a peripheral action, anesthetizing the stretch or cough receptors of vagal afferent fibers, which are located in the respiratory passages,
Local anesthetic activity when applied topically to the mucosa.
Adverse CNS effects have been reported during use.
Bizarre behavior, including mental confusion and visual
Infant risk cannot be ruled out.
Swallow capsules whole; do not break, chew, crush, or dissolve; if capsules are chewed or dissolved in the mouth, oropharyngeal anesthesia may occur and could lead to choking.
Do not administer 2 doses at one time.
The majority of benzonatate exposures require only supportive care. If patients present soon after exposure, activated charcoal may be considered; however, as the drug is rapidly absorbed and there is a risk of
Management of Severe Patients with CNS depression, recurrent
Wash with soap and water. If a patient experiences a
Irrigate with water.
An adult survived an ingestion of 3600 mg after experiencing
Death has been reported in an 18-month-old child who ingested 2 to 10 capsules of benzonatate. An adolescent developed
This drug may cause nausea, dizziness, headache, sedation, or somnolence.
Tell patient that capsule should be swallowed whole. Oropharyngeal anesthesia may occur if capsules are chewed or dissolved in the mouth.